Navigation Links
Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
Date:5/9/2011

ce Sheets(In thousands, except share and par value amounts)March 31,December 31,20112010(Unaudited)AssetsCurrent assets:Cash and cash equivalents

$
39,634$
24,926Investment securities, available-for-sale

36,94667,440Prepaid expenses and other current assets

1,0562,502Total current assets

77,63694,868Property and equipment, net

774894Restricted cash

881881Other assets

107203Total assets

$
79,398$
96,846Liabilities and stockholders' equity Current liabilities:Accounts payable and accrued expenses

$
5,047$
,355Deferred revenue, current portion

3,4293,517Long-term debt, current portion

1,0672,416Total current liabilities

9,54316,288Deferred revenue, less current portion

44,57146,311Other long-term liabilities

428459Commitments and contingenciesStockholders’ equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at March 31, 2011 and December 31, 2010; noshares issued and outstanding at  March 31, 2011 and December 31, 2010--Common stock, $.001 par value, 100,000,000 sharesauthorized at March 31, 2011 and December 31, 2010;48,078,553 and 47,767,313 shares issued and outstanding at March 31, 2011 and December 31, 2010, respectively

4848Additional paid-in capital

355,056352,401Accumulated other comprehensive income (loss)

7(9)Accumulated deficit

(330,255)(318,652)Total stockholders’ equity

24,85633,788Total liabilities and stockholders’ equity

$
79,398$
96,846Orexigen Therapeutics, Inc.Statements of Operations(In thousands, except per share amounts) (Unaudited)Three Months Ended March 31, 20112010Revenues:Collaborative agreement $

857$

-License revenue 97122Total revenues 1,82822Operating expenses:Research and development 6,5677,981General and administrative 6,7596,021Total operating expenses 13,32614,002Loss from operations (11,498)(13,980)Oth
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
2. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
3. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
4. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
5. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
6. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
7. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
8. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
9. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
10. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
11. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners ... Future to Benefit the Radiation Oncology Institute (ROI), hosted ... at Golden Gate Park in San Francisco.  ... Moore , CEO of Radiation Business Solutions, "but ... have raised over $70,000 for the ROI this year. ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
(Date:9/20/2014)... New PharmaPoint Drug Evaluation report, ... 2023?. The asthma market saw very slow growth ... saturated with relatively efficacious standard therapies, such as ... and long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and ... the launch of seven novel targeted biologic agents ...
(Date:9/20/2014)... 2014 Traditionally dentists have advised their patients ... Charlotte Dentistry is re-visiting that advice and changing his ... coffee and wine have on oral health. “There’s good news ... coffee may be beneficial in protecting against gum disease, and ... study on coffee was from the September 2014 issue ...
(Date:9/20/2014)... September 20, 2014 QueenBeeTickets.com is ready ... star’s tour performances. She will visit many cities in ... until the 16th of April. , Click Here ... Tour tickets at QueenBeeTickets.com. , The star’s fans are ... see their favorite young singer in a live performance. ...
(Date:9/20/2014)... Everett, WA (PRWEB) September 20, 2014 “Motherhood ... Health Center of Snohomish in their latest article , ... the best that you can—and that’s what we want to ... what services they need and should expect from their Family ... the following days of new motherhood. , To learn ...
(Date:9/19/2014)... “Copay coupons,” a drug manufacturer marketing tactic ... patients with prescription drug coverage, may now be infiltrating ... from the Department of Health and Human Services ... prohibit suppliers from offering side-payments to increase sales of ... The report highlights that two recent surveys, including one ...
Breaking Medicine News(10 mins):Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2
... Rental Suites ... On Track to Open in Late 2008, BETHESDA, Md., Feb. ... managed by Sunrise,Senior Living, Inc. (NYSE: SRZ ), continues to ... 140 condominiums have already,been reserved to date and construction on the ...
... revolution taking place,and it,s changing the face of cold-beverage ... that,s more sophisticated than traditional,sodas. Many are looking for ... past, finding a healthy and delicious bottled,drink was no ... are,definitely something to get excited about., "The beverage ...
... MedCath Corporation,(Nasdaq: MDTH ) announced today that ... relationship with Solaris Health System of Edison, N.J., ... new venture to manage the,catheterization laboratories of Solaris,s ... Regional Medical Center. Solaris, local,cardiologists, and MedCath will ...
... LOS ANGELES, Feb. 19 With Presidential,candidates campaigning ... basis,California cosmetic dentist Michael Kosdon has had ample ... observations, Dr. Kosdon has,picked a winner., "I ... brighter, more,crowd-pleasing smile than Hillary Clinton," says Kosdon, ...
... OREM, Utah, Feb. 19 Aribex, Inc., the ... NOMAD Pro, the,most-advanced intraoral X-ray system available. The ... NOMAD X-ray system., (Photo: http://www.newscom.com/cgi-bin/prnh/20080219/LATU057 ), ... that dental radiography is,performed by allowing an operator ...
... Company will donate money to non-profit organizations supporting medication, error prevention ... ... wristband, SAN BRUNO, Calif., Feb. ... announced the launch of a new,brand awareness campaign to focus public ...
Cached Medicine News:Health News:Fox Hill Senior Condominium Development Thrives During National Housing Slump 2Health News:Fox Hill Senior Condominium Development Thrives During National Housing Slump 3Health News:Fox Hill Senior Condominium Development Thrives During National Housing Slump 4Health News:The Search for Healthier Drinks Turns Up Yerba Mate 2Health News:MedCath Announces Venture With Two New Jersey Hospitals 2Health News:MedCath Announces Venture With Two New Jersey Hospitals 3Health News:Smiling on the Campaign Trail - Cosmetic Dentist Michael Kosdon Rates the Candidates 2Health News:Aribex Unveils New Handheld Intraoral X-ray System - NOMAD Pro 2Health News:First DataBank Launches Campaign to Focus Public and Industry Attention on Medication Error Prevention 2Health News:First DataBank Launches Campaign to Focus Public and Industry Attention on Medication Error Prevention 3
... Until now, laborious custom fabrication was required ... was limited and modifications in response to ... cumbersome.,The GunSlinger evolved from two years of ... teaching hospital. This orthosis can be quickly ...
... abduction of shoulder, elbow, wrist, and hand. ... is supported by the opposite shoulder. Abduction ... Foam arm support attaches to pillow wedge ... be attached anywhere along length of arm. ...
... is designed for the management of ... fractures. The lightweight anatomical design achieves ... for optimal control of humeral segments ... the shoulder and elbow joints. It ...
Provides secure fracture immobilization while allowing for full range of motion at shoulder and elbow...
Medicine Products: